Co-Delivery of Docetaxel and Bortezomib Based on a Targeting Nanoplatform for Enhancing Cancer Chemotherapy Effects

Drug Delivery - United Kingdom
doi 10.1080/10717544.2017.1362677
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Perspectives of Nanoemulsion Assisted Oral Delivery of Docetaxel for Improved Chemotherapy of Cancer

Drug Delivery
MedicinePharmaceutical Science
2014English

Tumor-Targeting, pH-sensitive Nanoparticles for Docetaxel Delivery to Drug-Resistant Cancer Cells

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2015English

Mitochondria-Specific Anticancer Drug Delivery Based on Reduction-Activated Polyprodrug for Enhancing the Therapeutic Effect of Breast Cancer Chemotherapy

English

Targeting Endosomal pH for Cancer Chemotherapy

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2018English

Ferromagnets-Based Multifunctional Nanoplatform for Targeted Cancer Therapy

2011English

Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery

English

Stimuli-Responsive PolymerProdrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy

English

Clinical Study of Long-Term Docetaxel Based Chemotherapy Treatment for Patients With Castration-Resistant Prostate Cancer

Japanese Journal of Urology
Urology
2014English

The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer After Failing to 5-Fluorouracil Based Chemotherapy

Cancer Research and Treatment
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy